| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $593K | -13.2% |
| R&D Expense | $35.3M | -4.1% |
| SG&A Expense | $14.2M | +14.0% |
| Operating Income | -$49.0M | -0.6% |
| Pre-tax Income | -$45.9M | -0.9% |
| Income Tax | $0 | — |
| Net Income | -$45.9M | -0.9% |
| EPS (Basic) | -$0.69 | +27.4% |
| EPS (Diluted) | -$0.69 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.5M | -66.1% |
| Short-term Investments | $40.8M | +1.4% |
| Accounts Receivable | $182K | -76.5% |
| Current Assets | $60.1M | -36.7% |
| Total Assets | $61.9M | -36.3% |
| Current Liabilities | $16.4M | +22.1% |
| Total Liabilities | $16.5M | +15.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.9M | -0.6% |
| Capital Expenditures | $44K | -45.0% |
| Investing Cash Flow | $1.3M | -90.2% |
| Financing Cash Flow | $2.6M | -95.2% |
| Free Cash Flow | -$38.0M | -0.5% |
| +27.4% |
| Stockholders' Equity |
| $45.4M |
| -45.3% |